1YQJ

Crystal Structure of p38 Alpha in Complex with a Selective Pyridazine Inhibitor

Summary for 1YQJ

• Entry DOI: 10.2210/pdb1yqj/pdb
• Descriptor: Mitogen-activated protein kinase 14, SULFATE ION, 6((S)-3-BENZYLPIPERAZIN-1-YL)-3-(NAPHTHALEN-2-YL)-4-(PYRIDIN-4-YL)PYRAZINE, ... (4 entities in total)
• Functional Keywords: transferase
• Biological source: Homo sapiens (human)
• Cellular location: Cytoplasm (By similarity): Q16539
• Total number of polymer chains: 1
• Total formula weight: 42552.57

Authors

Tamayo, N.,Liao, H.,Goldberg, M.,Syed, R.,Li, V.,Powers, D.,Tudor, Y.,Yu, V.,Wong, M.L.,Henkle, B.,Middelton, S.,Harvey, T.,Jang, G.,Hungate, R.,Dominguez, C. (deposition date: 2005-02-01, release date: 2005-04-26, Last modification date: 2023-08-23)

Primary citation

Tamayo, N.,Liao, L.,Goldberg, M.,Powers, D.,Tudor, Y.Y.,Yu, V.,Wong, L.M.,Henkle, B.,Middleton, S.,Syed, R.,Harvey, T.,Jang, G.,Hungate, R.,Dominguez, C.
Design and synthesis of potent pyridazine inhibitors of p38 MAP kinase.
Bioorg.Med.Chem.Lett., 15:2409-2413, 2005

PubMed Abstract: Novel potent trisubstituted pyridazine inhibitors of p38 MAP (mitogen activated protein) kinase are described that have activity in both cell-based assays of cytokine release and animal models of rheumatoid arthritis. They demonstrated potent inhibition of LPS-induced TNF-alpha production in mice and exhibited good efficacy in the rat collagen induced arthritis model.

PubMed: 15837335
DOI: 10.1016/j.bmcl.2005.02.010

Experimental method

X-RAY DIFFRACTION (2 Å)